Although weekly infusions over 5 weeks of ETC-216 or ApoA-1 Milano (an HDL mimetic) produced significant regression of coronary atherosclerosis in ACS patients, this study has several limitations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback